Your browser doesn't support javascript.
loading
Pulmonary Mycobacterium abscessus infection treated in combination with inhaled tigecycline.
Pedersen, Andreas Arnholdt; Fløe, Andreas; Løkke, Anders; Hilberg, Ole.
Afiliación
  • Pedersen AA; Department of Pulmonary Research, Lillebaelt Hospital, Vejle, Denmark Andreas.Arnholdt.Pedersen@rsyd.dk.
  • Fløe A; Department of Regional Health Reserarch, University of Southern Denmark, Odense, Denmark.
  • Løkke A; Mycobacterial Centre for Research Southern Denmark, Odense, Denmark.
  • Hilberg O; Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus N, Denmark.
BMJ Case Rep ; 16(12)2023 Dec 16.
Article en En | MEDLINE | ID: mdl-38103902
ABSTRACT
Pulmonary disease caused by Mycobacterium abscessus is difficult to treat, as there is currently no reliable evidence-based treatment. Treatment is long, complex and has many side effects. In this case, we report a patient with treatment-refractory pulmonary M abscessus disease, treated with inhaled tigecycline. Treatment with inhaled tigecycline lasted 15 months with comparably limited side effects. There were no positive mycobacterial cultures in the follow-up period of 2 years. Inhaled tigecycline is an option in the treatment of pulmonary M. abscessus when first-line treatment fails. Additional research should investigate this further.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mycobacterium abscessus / Infecciones por Mycobacterium no Tuberculosas Límite: Humans Idioma: En Revista: BMJ Case Rep Año: 2023 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Mycobacterium abscessus / Infecciones por Mycobacterium no Tuberculosas Límite: Humans Idioma: En Revista: BMJ Case Rep Año: 2023 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: Reino Unido